ArticleArchives of oral biology2026
Stimulated whole salivary flow is correlated with xerostomia severity and unstimulated whole salivary flow in adults with xerostomia taking anticholinergic medications.
Article in Archives of oral biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesThis study primarily investigated whether stimulated whole salivary (SWS) flow is correlated with minor salivary flow (MSF) in adults with xerostomia taking anticholinergic medications, and, secondarily, examined correlations between SWS and unstimulated whole salivary (UWS) flow and xerostomia severity.
designWe conducted a cross-sectional study of 85 middle-aged adults (mean age: 57.1 ± 5.2 years, range: 45-64) taking anticholinergic medications. Salivary flow rates for SWS, UWS, and labial MSF were measured, and xerostomia severity was assessed using the Xerostomia Inventory (XI). Based on established cutoff values for SWS and UWS, participants were grouped into categories with or without UWS or SWS hyposalivation, and into a combined SWS and UWS hyposalivation category. Correlation and multivariable regression analyses were conducted to examine associations among SWS, MSF, UWS, XI, and anticholinergic burden, with adjustments made for age, sex, and comorbidities.
resultsSWS was moderately and significantly correlated with MSF. Lower SWS was also significantly correlated with lower UWS and greater xerostomia severity. Women exhibited significantly lower SWS and MSF flow rates and reported higher XI scores compared with men. Subjects with combined SWS and UWS hyposalivation had the lowest MSF rates, whereas participants without hyposalivation had the highest (p = 0.0002).
conclusionsOur findings indicate that SWS flow is associated with xerostomia severity and with UWS flow in adults with xerostomia taking anticholinergic medications. However, SWS and UWS hyposalivation did not always co-occur according to established thresholds, suggesting that measuring both may improve the characterization of salivary dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.